SQ-109
- Generic Name
- SQ-109
- Drug Type
- Small Molecule
- Chemical Formula
- C22H38N2
- CAS Number
- 502487-67-4
- Unique Ingredient Identifier
- 9AU7XUV31A
Overview
SQ-109 is an orally active, small molecule antibiotic for treatment of pulmonary TB. Currently in Phase I clinical trials, SQ-109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and shorten the TB treatment regimen.
Background
SQ-109 is an orally active, small molecule antibiotic for treatment of pulmonary TB. Currently in Phase I clinical trials, SQ-109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and shorten the TB treatment regimen.
Indication
Investigated for use/treatment in bacterial infection, infectious and parasitic disease (unspecified), and tuberculosis.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.